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Study Importance Questions 
What is already known about this subject? 
• In people who are lean, dorsal striatal dopamine (DA) release, measured by using 
positron emission tomography (PET), is greater during fed than fasted conditions. 
• Presentation of palatable food without consumption stimulates striatal DA release during 
overnight fasted conditions in individuals who are lean and in individuals with obesity 
and binge eating disorder. 
 
What does your study add? 
• Viewing high-calorie food images increases striatal DA release when compared with 
low-calorie food images in people with obesity and prediabetes, but the response is the 
same during fed and fasted conditions. 
• DA release in response to high-calorie food images compared with low-calorie food 
images is greater in the nucleus accumbens than in the dorsal striatum, suggesting the 
nucleus accumbens is involved in regulating the motivation to obtain pleasurable reward 







Objective: To determine whether striatal dopamine (DA) release is affected by food ingestion 
and whether the DA response to high-calorie food images is greater in the fasted than fed state in 
people with obesity.  
Methods: Striatal DA release was evaluated in 10 people with obesity and prediabetes after 
participants consumed a meal to satiation and after they fasted overnight, and in response to 
viewing images of high-calorie compared with low-calorie foods after consuming a meal to 
satiation or fasting overnight, by using positron emission tomography with [11C]raclopride 
injection.  
Results: Striatal DA D2/D3 receptor availability was not different during fasted and fed 
conditions. Viewing images of high-calorie foods induced striatal DA release relative to viewing 
images of low-calorie foods (p<0.05), but there was no difference in the magnitude of the 
response between fasting and fed conditions.  
Conclusions: People with obesity and prediabetes do not increase striatal DA release after eating 
a meal to satiation compared with fasting overnight, and fail to inhibit DA release in response to 
high-calorie food stimuli after eating a meal to satiation. These data suggest impaired DA 






Obesity is a major public health problem in many countries because of its high 
prevalence, causal relationship with serious medical comorbidities and economic effects of 
increased health care costs and work absenteeism (1). In all persons, obesity is caused by 
ingesting more energy than expended (and needed for organ growth and development in children 
and adolescents) over a long period of time. This initial positive energy balance generates an 
accumulation of body fat, which must be maintained by continued high-energy intake.  
The brain is the major regulator of energy intake and controls appetite through integration 
of hedonic and homeostatic mechanisms (2). The neurotransmitter, dopamine (DA), has a central 
role in regulating reward-motivating behavior with mesolimbic and nigrostriatal dopaminergic 
signaling in the ventral and dorsal striatum, respectively, required for encoding reward-predictive 
cues and the motivation to ingest palatable food (3). DA D2/D3 receptor (D2/D3R) availability 
and DA release can be assessed by using DA signaling-related radioligands in combination with 
positron emission tomography (PET).  By using this technique, an increase in striatal DA release 
has been observed in people without obesity after consumption of a palatable milkshake (4) or a 
favorite meal (5) and after presentation of palatable food without consumption (6). In contrast, 
considerably less is known about DA responses to food cues in people with obesity. Presentation 
of palatable food without consumption has been shown to stimulate striatal DA release in the 
overnight fasted state in people with obesity and binge eating disorder (BED) (7) but it is unclear 
whether feeding modulates this response. In addition, it is currently unknown whether feeding 
elicits striatal DA release in people with obesity, however, a reduced DA response to glucose 
ingestion has been reported (8) suggesting the DA response to feeding is altered in people with 





The main objectives of the present study were to assess striatal DA release in response to 
consuming a high-calorie meal relative to having fasted overnight and in response to viewing 
high-calorie food images compared with low-calorie food images during both fasted and fed 
conditions in people with obesity and insulin resistance, defined by having prediabetes. PET with 
[11C]raclopride, a nonselective D2/D3R radioligand that is displaced by increased intra-synaptic 
DA (9), was used to measure striatal D2/D3R availability after eating a meal to satiation 
compared with overnight fasting conditions and striatal DA release induced by viewing high-
calorie compared with low-calorie food images during both fed and fasted conditions. The dorsal 
and ventral striatal regions were specifically evaluated because these locations contain the 
highest density of D2/3R in the brain (10) and are involved in reward processing, including 
viewing and consuming palatable foods (4-6). We hypothesized that D2/D3R availability after 
the meal would be lower due to meal-induced DA release and DA release in response to the 
high-calorie food images would be greater during fasted than fed conditions, indicating a 
modulating effect of hunger on DA release.  
 
METHODS 
Study Participants  
Ten men (n = 5) and women (n = 5) with obesity completed this study (Table 1). Written, 
informed consent was obtained from all participants before their participation in this study, 
which was approved by the Human Research Protection Office and the Radioactive Drug 
Research Committee at Washington University School of Medicine in St. Louis, MO. All 
participants completed a comprehensive evaluation in the Clinical and Translational Research 





and physical examination, standard blood tests, hemoglobin A1c (HbA1c), a 2-h oral glucose 
tolerance test (OGTT), and dual-energy x-ray absorptiometry scan to assess body fat and fat-free 
masses (DXA, Lunar iDXA, GE Healthcare Lunar, Madison, WI). Participants were eligible if 
their body mass index was ≥30 kg/m2 and they had prediabetes, defined as either HbA1c 5.7-
6.4%, fasting plasma glucose concentration of 100-125 mg/dl or 2-h OGTT plasma glucose 
concentration of 140-199 mg/dl. People with prediabetes were specifically studied to decrease 
the heterogeneity in insulin sensitivity among participants, which could affect DA signaling (11). 
Potential participants with a history of diabetes, that smoked more than 10 cigarettes per week, 
used drugs or medications that can affect DA signaling, consumed excessive amounts of alcohol 
(>21 units of alcohol per week for men and >14 units of alcohol per week for women), had metal 
implants that would interfere with the imaging procedures, and were post-menopausal, pregnant 
or lactating were excluded. All participants were screened for recent drug use by using a urine 
drug screen (iCup, Redwood Toxicology Laboratory, Santa Rosa, CA). All but one participant 
tested negative for drug use; this participant tested positive for benzodiazepine use, which was 
prescribed as needed for anxiety by their primary care physician.    
 
Study Design  
Eating behavior characteristics of the participants were assessed by using validated  
questionnaires that assessed different aspects of eating behavior: i) Questionnaire on Eating and 
Weight Patterns – Revised (QEWP-R; (12)), Questionnaire on Eating and Weight Patterns – 5 
(QEWP-5; (13)) and the Eating Disorder Examination Questionnaire (EDE-Q; (14)) to identify 
BED; ii) Dutch Eating Behavior Questionnaire (DEBQ; (15)) to assess restrained, emotional, and 





by using criteria based on substance dependence diagnosis; and iv) the Food Craving Inventory 
(FCI; (17)) to assess craving for different types of food.  
The study design schema for a single study visit under fasted or fed conditions is shown 
in Figure 1. Each participant completed two PET studies in randomized order, 19 ± 6 days apart. 
On both occasions, participants fasted for 12 h overnight at home before being admitted to the 
CTRU where they either continued to fast or consumed a high-calorie meal, self-selected from 
the hospital cafeteria menu, until satiated. Approximately 30 min after continued fasting or after 
finishing the meal, participants rated their current level of hunger, satisfaction with their hunger 
state, fullness, and how much they could eat (scale from 0 to 100). Participants then underwent a 
brain PET scan (Siemens Biograph mMR, Siemens, Malvern, PA) in the Center for Clinical 
Imaging Research (CCIR) in conjunction with a bolus intravenous injection of 6-19.4 mCi 
[11C]raclopride. [11C]raclopride was prepared  by using an automated adaptation of published 
methods (18, 19). Radiochemical purity was >99.5% and specific activity was ≥1104 Ci/mmol 
(40.8 TBq/mmol). Emission data were collected in 3D mode for 40 frames (30 x 1 min frames; 9 
x 2 min frames; 1 x 3 min frame) over 51 min. Structural MR T1-weighted anatomical images 
were obtained during each PET scan to localize regions of interest (ROI) by using a 3-D 
Magnetization Prepared Rapid Acquisition Gradient Echo (MP-RAGE) sequence (sagittal 
orientation, TR = 2300 ms, TE = 2.95 ms, flip angle = 9º, slab thickness = 176 mm, FOV = 240 x 
256 mm, voxel dimensions = 1 x 1 x 1 mm) in combination with structural T2-weighted 
anatomical images (t2_spc_sag_p2_iso, sagittal orientation, TR = 3200 ms, TE = 418 ms, flip 
angle = 120º, slab thickness = 176 mm, FOV = 256 x 256 mm, voxel dimensions = 1 x 1 x 1 





During the first 15 s of the PET scan, participants were shown task instructions. 
Participants were then shown 96 low-calorie food images for 15 s each over a total of 25 min 
followed by 96 high-calorie food images for 15 s each over the subsequent 25 min (Figure 1). 
Low-calorie food, rather than non-food, image viewing, was chosen as the ‘control’ condition to 
ensure that striatal responsivity to high-calorie food images was due to the high-calorie nature of 
the images and not to nonspecific features such as simply the act of viewing food images. The 
presentation of high-calorie food images began at 25 min post-[11C]raclopride injection, 
consistent with theoretical and validation studies using the single-dose radiotracer method (20-
22). A fixation cross was presented for 0.5 s between each food image. Food images (Table S1) 
were selected from a database containing images that have previously been used to examine 
differences in brain activation responses to high-calorie and low-calorie images (23, 24). High-
calorie foods included sweet (e.g., candy, chocolate, cake) and savory (e.g., French fries, burger, 
pizza) foods, whereas low-calorie foods included vegetables, fruit, and salad. All images had the 
same resolution and color depth and had the same background color and distance from the 
camera. E-Prime (Psychology Software Tools, Sharpsberg, PA) software was used to present 
randomized images within each low-calorie and high-calorie block and collect the participants’ 
responses. During food image presentation, participants rated whether they liked, disliked, or felt 
neutral towards the thought of eating the food presented by using an E-Prime serial response 
(SR) box (Psychology Software Tools). Rating results from two participants were excluded from 
this analysis because the SR box failed to record one participant’s responses during their fed 
study and another participant did not understand the directions during the low-calorie food image 






PET data analyses 
Regions of interest (ROIs). The dorsal striatum (whole caudate and whole putamen) and 
ventral striatum (nucleus accumbens) were identified by using FreeSurfer (25). The dynamic 
PET images were aligned with each other and co-registered to the individual’s MP-RAGE 
image, as previously described (26). Striatal ROIs and the cerebellar reference region were 
resampled in the same atlas space (26). The whole cerebellar region was used as the reference 
region because [11C]raclopride does not accumulate in this region (27) and was segmented by 
using the spatially unbiased infra-tentorial template (SUIT) toolbox (28) in Matlab R2018b 
(MathWorks; Natick, MA). Decay-corrected time-activity curves showing radioactivity 
concentration as a function of time were extracted for each ROI and cerebellum from the 
dynamic 50 min PET scan. An example time-activity curve and fit to the data using the 
LSSRM/Bayesian compared to the Logan model (described below) is presented in Figure 2. 
Assessment of DA D2/D3R Availability, DA Release, and Signal-to-Noise Ratio. To 
assess DA responses in the fasting and fed states we determined: i) D2/D3R binding potentials 
(BPNDs) to compare DA release in the fed and fasted states during the entire 50 min PET scan; 
and ii) the change in displacement of [11C]raclopride from D2/D3R (change in DA release) in 
response to viewing high-calorie compared with low-calorie food images. BPNDs and the change 
in DA release in response to viewing high-calorie and low-calorie food images were calculated 
for each ROI by using a linear extension of the simplified reference region model (LSSRM) (29). 
A Bayesian method (30) was used to estimate the kinetic parameters, R, k2, k2a, and γ used in the 
LSSRM model, in which R is the ratio of transport rates for the binding and reference regions, k2 
represents the clearance of nonspecifically bound radiotracer, k2a represents dissociation from the 





[11C]raclopride, from D2/D3R due to additional synaptic DA released in response to a given 
stimuli (viewing high-calorie food images) presented during the PET scan (22). D2/D3R BPND 
were calculated as k2/k2a -1 by using dynamic data collected throughout the entire 50 min PET 
scan. A similar D2/D3R BPND in both PET scans indicates no difference in DA release over the 
entire 50 min PET scan in the fasted and fed states, whereas a lower D2/D3R BPND in the fed 
state would indicate greater displacement of [11C]raclopride from D2/D3R as a result of food 
ingestion-induced DA release, as previously shown in people who are lean (5). Our study design 
does not measure absolute DA release separately during periods of viewing low-calorie and 
high-calorie food images. However, a delta DA release value can be calculated (γ value) 
indicating the change in DA release from viewing low-calorie to high-calorie food images 
(Figure 2). For each ROI, the γ value provided an index of DA release in response to viewing 
images of palatable, high-calorie foods relative to viewing low-calorie food images. γ values 
were limited to 0 and above. The rate at which transient task-induced DA release returns to 
baseline, τ, was specified as 0.23 min-1, based on an ROI-derived γ-weighted average τ in 6 
initial participants. Signal-to-noise ratio (SNR) was estimated by dividing γ by the standard 
deviation (SD) of γ.  
The LSSRM was specifically developed to analyze time-dependent radioligand 
displacement during a PET scan allowing alterations in DA release in response to a given stimuli 
to be modeled. The LSSRM model has been validated and successfully applied to analyze the 
effect of different reward processing, cognitive and motor tasks during a single PET scan 
negating the need for multiple PET scans thereby lowering subject burden and radiation 
exposure (21, 22, 31). In contrast, the commonly-used Logan graphical method (32) does not 





performed for each stimuli/intervention studied. For example, if the Logan approach was 
exclusively used in the present study 4 separate PET scans would have been required (i.e., 
fasting state viewing low-calorie images, fasting state viewing high-calorie images, fed state 
viewing low-calorie images and fed state viewing high-calorie images).  
 
Statistical analyses.  
Our power calculations were based on previously published changes in DA release in the 
dorsal striatum in response to meal presentation in people with obesity and BED (7) and in 
individuals who are lean (6) where Cohen’s d effect sizes of 1.20 and 1.43 were reported, 
respectively (6, 7). Using the smaller effect size, a sample size of 10 subjects and 2-tailed tests, 
we estimated we had sufficient power (>0.90) to detect statistically significant differences in 
D2/D3R BPND and DA release in the present study at the ≤0.05 significance level.  
Differences in appetitive ratings between fasted and fed states were assessed by using 
Student’s t-test for paired samples.  A two-way [condition (fasted vs. fed) x type of food image 
(low- vs. high-calorie) repeated measures analysis of variance (ANOVA) was used to evaluate 
the effects of feeding and type of food cue on perceived enjoyment of eating the food presented 
with Tukey’s post hoc procedure used to identify significant mean differences. Three-way [brain 
region (dorsal striatum vs. nucleus accumbens) x condition (fasted vs. fed) x method 
(LSSRM/Bayesian vs. Logan)] repeated measures ANOVA was used to evaluate the effects of 
brain region, feeding and method on D2/D3R BPND. Correlations between LSSRM/Bayesian and 
Logan-derived BPND were assessed by using Pearson’s product-moment correlation. Two-way 
[brain region (dorsal striatum vs. nucleus accumbens) x condition (fasted vs. fed)] repeated 





images on LSSRM/Bayesian-derived γ and SNR values. In addition, separate one-sample t-tests 
were performed to determine whether γ and SNR were greater than 0 for each ROI during fasted 
and fed conditions. Analyses were conducted using SPSS (Version 25, IBM, Armonk, NY). Data 




Hunger and pleasure induced by viewing food images  
For the study conducted during the fed state, participants consumed 586 ± 106 kcal (16 ± 
2% protein, 46% ± 7% carbohydrate, and 38 ± 5% fat) in the morning 30 min before PET 
scanning was performed. Participants rated themselves as hungrier during the fasted than the fed 
condition (Table 2). In addition, perceived enjoyment of eating was greater when viewing high-
calorie than low-calorie food images (main effect of food image type, p = 0.002), and when 
viewing high-calorie foods in the fasted than in the fed state (p < 0.05; Table 2). 
 
Eating behavior characteristics 
 Participants reported mild disordered eating behaviors and food cravings but few reported 
addiction-like eating behavior. However, all participants reported persistent desire or repeated 
unsuccessful attempts to decrease the consumption of foods high in fat and sugar (Table 3). One 
participant had evidence of BED based on their responses to the QEWP-5. Eliminating this 







Striatal D2/D3R availability in the fed and fasted states 
Values for D2/D3R BPND were ~5% higher when using the LSRRM/Bayesian than the 
Logan graphical method (main effect, p < 0.001; Figure 3A), and there was a strong correlation 
between D2/D3R BPND values obtained using each approach (r = 0.96; p < 0.0001) (Figure 3B). 
The small difference in D2/D3R BPND between mathematical models was expected because the 
Logan graphical method does not include a parameter (γ) representing stimuli-evoked DA 
release during the PET scan. These data demonstrate the validity of using the LSSRM/Bayesian 
approach in the current study design to accurately determine BPND in which DA release during a 
single scanning period can change when viewing images of high-calorie foods.  
Ingestion of a palatable meal did not affect DA release, as there was no difference in 
D2/D3R BPND between the fasted and fed states (main effect of condition, p = 0.91). However, 
D2/D3R BPND was ~30% higher in the dorsal striatum than in the nucleus accumbens (main 
effect of region, p < 0.001) (Figure 3A), as expected because of the greater number of D2/D3R 
in the dorsal striatum (33). 
 
Striatal DA release in response to viewing high-calorie food images 
Displacement of the DA receptor radioligand [11C]raclopride from D2/D3R due to 
additional synaptic DA release (γ) in response to viewing images of high-calorie foods relative to 
viewing low-calorie foods was greater than zero in the dorsal striatum and nucleus accumbens 
during both fasted and fed conditions (p < 0.05 for all comparisons; Figure 3C). However, the 
extent of synaptic DA release during the fasting condition was not different than during the fed 
condition (p = 0.64), but was 2-4-fold greater in the nucleus accumbens than in the dorsal 





decrease in [11C]raclopride signal when stimuli change from low-calorie to high-calorie food 
images. The SNR for γ was also significantly greater than 0 in all conditions (p < 0.01 for all 
comparisons), but did not differ between fasted and fed conditions (p = 0.43) or between dorsal 
striatum and nucleus accumbens (p = 0.11) (Figure 3D).  
 
Discussion 
Non-homeostatic food intake cued by high-calorie food stimuli is regulated, in part, by 
central DA signaling (3). In the present study, we used brain PET in conjunction with the 
injection of [11C]raclopride, a displaceable nonselective D2/D3R radioligand, to measure striatal 
D2/D3R availability and DA release in people with obesity and prediabetes who viewed 
palatable, high-calorie food images during fasted and fed conditions. In contrast to previous 
observations in people who are not obese (5), we found meal ingestion did not affect striatal 
D2/D3R availability, indicating no effect on DA release relative to the fasting state, and that 
striatal DA release in response to viewing high-calorie relative to low-calorie food images was 
similar in the fasted and fed states in people with both obesity and prediabetes. These findings 
suggest reward region responsivity to high-calorie food ingestion is not adequately regulated in 
people with both obesity and prediabetes, thereby contributing to greater energy intake with 
meals.  
Few studies have evaluated the potential importance of food intake and viewing food 
images on brain activation and DA signaling in people. Moreover, we are not aware of any PET 
studies that used [11C]raclopride to evaluate DA release in people with obesity in both fasted and 
fed states. In people that are not obese, striatal activation in response to high-calorie food images, 





release, assessed by using PET with [11C]raclopride, was greater after consuming a palatable 
milkshake (4) or a favorite meal (5) and after presenting palatable food without consumption (6). 
In people with obesity, striatal activation, assessed by using fMRI, is increased in the fasting 
state in response to viewing high-calorie food images, and this activation was greater than that 
observed in people who are lean (35, 36). Our study extends these findings by demonstrating no 
difference in DA release between the fed and fasted states in contrast to previous findings in 
people that were not obese (5). Although we found an increase in striatal DA release in response 
to viewing high-calorie relative to low-calorie food images in people with obesity with 
prediabetes, the DA response was the same during fed and fasted conditions. Our findings and 
those of these previous fMRI and PET studies support the dynamic vulnerability and incentive 
sensitization hypotheses of obesity (37), which posit that persistent overeating of high-calorie 
foods reduces reward region responsivity to high-calorie food ingestion and instead results in 
increased incentive salience (“wanting”) prompted by conditioned food cues. The mechanism(s) 
responsible for altered striatal DA signaling in obesity is not known, but is possibly related to: i) 
changes in the levels of hypothalamic neuropeptides involved in energy homeostasis, such as 
leptin and ghrelin, which directly modulate the activity of dopaminergic neurons (38); ii) 
increased central insulin concentrations that act directly on the DA system (39); iii) altered 
glucose metabolism (40); and/or iv) greater catecholaminergic afferents arising from the 
hindbrain (41).  
We found DA release in response to high-calorie food images was greater in the nucleus 
accumbens (located in the ventral striatum) than in the dorsal striatum, which is analogous to 
responses to other rewarding stimuli, including alcohol (42), monetary reward (43) and 





striatum may be due to the functional importance of the former in incentive salience, which 
involves the motivation to obtain a pleasurable reward (“wanting”) (3). In contrast, the dorsal 
striatum plays a larger role in “action salience” (45), which increases the motivation to carry out 
the motor actions necessary to obtain the pleasurable reward. Our participants might have 
experienced “wanting” during exposure to high-calorie food images with less urge to act to 
obtain food, because there was no expectation that food would be consumed during the PET 
scan.  
Our study has several limitations. We purposely studied people with obesity who had 
prediabetes to reduce the heterogeneity in insulin sensitivity among participants, which could 
affect DA signaling (11) and make it more difficult to detect differences in fed and fasted 
conditions. It is therefore possible that our results might not translate to people with obesity and 
normal oral glucose tolerance. In addition, our study was conducted in a small number of 
participants, which could have failed to detect a difference between fed and fasted states and we 
did not evaluate DA signaling in a healthy comparator lean group. However, our a priori power 
calculations found the number of participants in our study (n=10) would be sufficient to detect a 
meaningful difference in DA release between the fasting and fed states that had been shown 
previously in people who were not obese. Moreover, the number of subjects included in the 
present study is greater than the number of subjects in a previous study (n=7) that reported an 
increase in striatal DA release in people without obesity after they consumed a favorite meal (5).  
In conclusion, we found striatal DA release after eating to satiety was not different than 
DA release after fasting for 12-hour overnight in people with obesity and prediabetes. These 
results differ from previous observations of greater striatal DA release in the fed than fasted state 





intake and sensitivity to food cues after initiating food consumption in people with obesity and 
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Figure 1. Schematic illustration of the study visit. Participants completed 2 PET scans 
performed in a randomized order. On each occasion participants arrived in the Research Unit in 
the fasting state then during the hour before each positron emission tomography/magnetic 
resonance (PET/MR) scan with [11C]raclopride injection they consumed a palatable meal or 
remained in the fasting state and completed appetitive ratings. During the PET/MR scan, 
participants rated images of low-calorie and high-calorie foods shown during the first and last 25 
min of the scan, respectively. Fixation crosses were shown for 0.5 s after each food image. 
Examples of low- and high-calorie food images are shown. 
 
Figure 2. Representative time activity curve (TAC) and fit to the [11C]raclopride radioactive 
signal in the nucleus accumbens for a single participant. The TAC in the cerebellar region of the 
same participant was used as the reference TAC because [11C]raclopride does not accumulate in 
this region. To assess DA responses in the fasting and fed states we determined: i) D2/D3R 
binding potentials (BPNDs) to compare DA release in the fed and fasted states during the entire 
50 min PET scan; and ii) the change in displacement of [11C]raclopride from D2/D3R (change in 
DA release) in response to viewing high-calorie compared with low-calorie food images. 
D2/D3R BPNDs were calculated based on the distribution volume ratio (DVR) with the 
distribution volume in each region of interest (ROI) related to the number of unoccupied binding 
sites and the DVR the ratio of the DV in a receptor-containing region (i.e., nucleus accumbens or 
dorsal striatum) to the cerebellum (i.e., the reference nonreceptor region). The vertical lines at 25 





food image condition. γ indicates [11C]raclopride displacement by endogenous dopamine release 
in response to viewing high-calorie relative to low-calorie food images. While γ is estimated 
using data from the entire positron emission tomography (PET) scan, the biggest effect on γ is 
due to the first few minutes after change from low-calorie to high-calorie food image condition 
since the linear extension of the simplified reference region model (LSSRM) assumes 
diminishing effect of changed conditions on dopamine release. The solid line indicates 
[11C]raclopride signal as predicted by a model in which γ = 0 (i.e., no high-calorie image-induced 
dopamine release).  
 
Figure 3. (A) Effect of consuming a meal to satiation on striatal dopamine D2/D3 receptor 
binding potential (D2/D3R BPND) assessed by using linear extension of the simplified reference 
region (LSSRM)/Bayesian and Logan graphical (Logan) models. (B) Relationship between 
D2/D3R BPND values obtained by using the LSRRM/Bayesian and the Logan graphical methods. 
Circles and triangles represent values for dorsal striatum and nucleus accumbens, respectively. 
(C) Striatal dopamine release (γ), estimated by using the LSSRM/Bayesian method, in response 
to viewing high-calorie compared with low-calorie food images during fed and fasted conditions. 
(D) Effect of feeding condition on signal-to-noise ratio of γ (SNR; γ/(SD of γ), estimated by the 
LSSRM/Bayesian method. Data are means ± SEM in panels A, C and D. *Values different from 






















Data are means ± SEM. Abbreviations: OGTT, oral glucose tolerance test; HbA1c, hemoglobin 
A1c; HDL, high-density lipoprotein. 
 
  
Age (yrs) 42 ± 3 
Body mass index (kg/m2) 39.4 ± 1.5 
Body fat (%) 46.8 ± 2.0 
Fasting glucose (mg/dl) 99 ± 4 
2-h OGTT glucose (mg/dl) 162 ± 7 
Fasting insulin (µU/ml) 23 ± 3 
HbA1c (%) 5.5 ± 0.1 
Triglyceride (mg/dl) 144 ± 17 





Table 2. Appetitive ratings and perceived enjoyment of eating low-calorie and high-calorie 
foods in the fasted and fed states. 
 Fasted Fed 
Appetitive ratings immediately before the PET study 
  
   How hungry are you? 45.7 ± 9.0 13.2 ± 5.1* 
   How full are you? 28.5 ± 8.7 67.6 ± 9.4* 
   How satisfied are you? 33.1 ± 8.5 79.0 ± 3.5* 
   How much can you eat? 58.4 ± 7.2 22.2 ± 5.2* 
Perceived enjoyment during the PET study   
   Eating low-calorie foods  1.52 ± 0.08 1.51 ± 0.07 
   Eating high-calorie foods  1.15 ± 0.02† 1.24 ± 0.05*† 
Data are means ± SEM. Appetitive ratings ranged from 0-100. Perceived enjoyment scores 
ranged from 1-3 with lower scores indicate greater “liking” of imagining eating the food depicted 
in the presented image. * Value significantly different from corresponding fasted value, p <0.05. 






















Table 3. Eating behavior characteristics 
Data are means ± SEM or frequency of occurrence. The Dutch Eating Behavior Questionnaire 
scores range from 1 (never) – 5 (very often) on each scale. Yale Food Addiction Scale symptom 
counts range from 0-8. Food Craving Inventory scores range from 1 (not at all) – 5 (nearly every 
day) for each food type. 
 
Dutch Eating Behavior Questionnaire  
   Restrained Eating Scale  2.3 ± 0.2 
   External Eating  Scale  3.0 ± 0.1 
   Emotional Eating Scale  2.2 ± 0.2 
   Clearly Labeled Emotions Scale  2.2 ± 0.2 
   Diffuse Emotions  Scale  2.5 ± 0.2 
Yale Food Addiction Scale  
   Symptom counts  2.1 ± 0.4 
   Substance taken in larger amount and for longer period than intended  1/10  
   Persistent desire or repeated unsuccessful attempts to quit  10/10 
   Much time/activity to obtain, use, recover  2/10  
   Important social, occupational, or recreational activities given up or reduced  0/10 
   Use continues despite knowledge of adverse consequences  4/10 
   Tolerance 3/10 
   Characteristic withdrawal symptoms; substance taken to relieve withdrawal  0/10 
   Use causes clinically significant impairment or distress 1/10 
   Food Dependence Diagnosis 1/10 
Food Craving Inventory  
   Fat  2.2 ± 0.2 
   Sweet 2.5 ± 0.2 
   Carbohydrate  2.1 ± 0.2 
   Fast-food Fat  2.9 ± 0.2 
